Metraipolis › archive › dc_64f9efc2bc5c

Trajectory of efficacy and safety across ulotaront dose levels in schizophrenia: a systematic review and dose-response meta-analysis — Europe PMC PMID:40795331

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40795331
DOI
10.1093/ijnp/pyaf059
License (as archived)
solo-consultazione
Archived
2026-11-10T05:30:23.557Z
SHA-256 of the archived text
52f6a29d72bd7e5fed77f2005af4627b9e7edfde2416d9d87fc04343663ec5da
Stable URL of this page
https://metraipolis.com/documento/dc_64f9efc2bc5c

How to cite

Trajectory of efficacy and safety across ulotaront dose levels in schizophrenia: a systematic review and dose-response meta-analysis — Europe PMC PMID:40795331 — Europe PMC (en), https://europepmc.org/article/MED/40795331 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_64f9efc2bc5c (Metraipolis archive dc_64f9efc2bc5c, sha256 52f6a29d72bd7e5fed77f2005af4627b9e7edfde2416d9d87fc04343663ec5da)
BibTeX
@misc{dc64f9efc2bc5c,
  title = {Trajectory of efficacy and safety across ulotaront dose levels in schizophrenia: a systematic review and dose-response meta-analysis — Europe PMC PMID:40795331},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40795331},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_64f9efc2bc5c; sha256 52f6a29d72bd7e5fed77f2005af4627b9e7edfde2416d9d87fc04343663ec5da},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40795331. Agents can read the archived copy with the MCP tool read_document.